Update on the merger approval process for the combination of Novozymes and Chr. Hansen: The parties have submitted a remedy proposal to the European Commission.
20 Noviembre 2023 - 1:03AM
Update on the merger approval process for the combination of
Novozymes and Chr. Hansen: The parties have submitted a remedy
proposal to the European Commission.
November 20, 2023
Please see attachment.
Contact information
Investor RelationsAnders Mohr Christensen+45
2515 2364dkamc@chr-hansen.com
Press RelationsSanne Seyer-Hansen+45 6038
6207dksash@chr-hansen.com
- 2023_Update on the merger approval process for the combination
of Novozymes and Chr. Hansen
Chr Hansen (TG:51C)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Chr Hansen (TG:51C)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024
